Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$26,033,919
+$6,585,964 QoQ
Shares Held
103,457
+15.7% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#528
of 4,153 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Horizon Investments, LLC holds $251,395,826 across 12 Drug Manufacturers - General names. ABBV ranks #4 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
57,355 | $68,793,313 | |
| 2 | JNJ |
Johnson & Johnson
|
251,838 | $63,959,296 | |
| 3 | MRK |
Merck & Co., Inc.
|
291,282 | $37,429,737 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
103,457 | $26,033,919 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
149,785 | $18,923,836 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
251,893 | $14,514,074 | |
| 7 | AMGN |
Amgen Inc
|
35,484 | $12,849,466 | |
| 8 | PFE |
Pfizer Inc
|
193,281 | $4,654,206 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,033,919 | 103,457 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $19,447,955 | 89,420 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $31,906,572 | 139,641 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $18,528,525 | 80,023 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,258,660 | 55,267 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,607,554 | 21,991 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $3,760,309 | 21,161 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,057,029 | 20,544 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,028,224 | 11,825 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $4,685,433 | 25,730 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,820,010 | 24,650 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $4,861,442 | 32,614 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,333,859 | 32,167 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,483,602 | 34,408 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $4,512,151 | 27,920 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,306,400 | 9,734 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,609,123 | 56,210 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,558,005 | 58,960 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,495,280 | 33,200 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $1,307,168 | 12,118 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $5,306,245 | 47,108 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,334,333 | 58,532 | Shares | Sole | 2021-05-14 | |
| 2020-09-30 | $4,023,884 | 45,940 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,243,916 | 73,782 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,784,509 | 49,672 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||